Stock Evaluator: Varex Imaging Corporation (VREX)

Varex Imaging Corporation VREX

$18.46 0.00 0.00%
August 19, 2026 4:00:00 PM EST November 10, 2021 Volume: 1,254,308
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.

Commentary & Analysis


Financial Summary

Share Statistics VREX Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $779.3 $407.7 41%
Shares Out (Mil) 42.6 41.3 44%
Institutional Ownership 98.4% 81.4% 79%
Float (Mil) 41.4 34.9 43%
Beta 0.88 0.88 53%
Avg Daily Volume (000s) 2,479 412 85%
Price Change
(52-week)
64.1% 64.8% 84%
Growth VREX Industry
Median
Percentile
(All Stocks)
Sales (5yr) 2.7% 11.8% 26%
Net Income (5yr) (4.0%) (6.0%) 35%
EPS (5yr) (2.6%) 10.4% 28
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (18.2%) (16.2%) 38%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 5 5 5
Current EPS $0.294 $0.888 $1.094
Month Ago EPS $0.292 $0.778 $1.064
# Rev Up 1 1 1
# Rev Down 0 0 1
Three Months Ago EPS $0.292 $0.780 $1.020
Year/Year Chg (20.5%) (152.2%) (170.6%)
Financials VREX Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $865 $119 48%
Net Income (TTM) (Mil) $22 ($9) 49%
EPS (TTM) $0.527 ($0.400) 54%
Operating Cash Flow (TTM) (Mil) $11 ($3) 39%
Net Cash Flow (TTM) (Mil) ($37) $1 21%
Long-Term Debt (Q1) (Mil) $356 $21 55%
Enterprise Value (Q1) (Mil) $1,076 $427 41%
Valuation VREX Industry
Median
Percentile
(All Stocks)
P/B 1.57 3.06 40%
P/E 35.6 27.8 75%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.7 na
Ratios VREX Industry
Median
Percentile
(All Stocks)
Gross Margin 34.3% 58.9% 41%
Net Margin 2.6% (6.9%) 40%
ROA 2.0% (12.7%) 56%
ROE 4.6% (13.1%) 43%
Liabilities to Assets 53.6% 46.0% 46%
F-Score 5 4 50%

Passing Stock Screens

As of 8/20/2026, from a list of 60 stock screening strategies, VREX meetings the criteria of 1 screen:

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors